Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism SRC inhibitors(Tyrosine-protein kinase SRC inhibitors), Syk inhibitors(Spleen tyrosine kinase inhibitors), p38α inhibitors(P38 α mitogen-activated protein kinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC43H49N7O9S |
InChIKeyFWXVGKSWZJEPQI-UHFFFAOYSA-N |
CAS Registry1630202-02-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis, Ulcerative | Phase 2 | UA | - | |
Colitis, Ulcerative | Phase 2 | LV | - | |
Colitis, Ulcerative | Phase 2 | HU | - | |
Colitis, Ulcerative | Phase 2 | UA | - | |
Colitis, Ulcerative | Phase 2 | HU | - | |
Colitis, Ulcerative | Phase 2 | LT | - | |
Colitis, Ulcerative | Phase 2 | PL | - | |
Colitis, Ulcerative | Phase 2 | PL | - | |
Colitis, Ulcerative | Phase 2 | LV | - | |
Colitis, Ulcerative | Phase 2 | LT | - |